---
title: "AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292650413.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-14T14:14:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292650413.md)
  - [en](https://longbridge.com/en/news/292650413.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292650413.md)
---

# AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [688192.CN](https://longbridge.com/en/quote/688192.CN.md)

## Related News & Research

- [AstraZeneca’s Etcamah-CDK4/6 combo wins EU approval for 1st-line advanced ER-positive breast cancer](https://longbridge.com/en/news/293566585.md)
- [J.P. Morgan Sticks to Their Buy Rating for AstraZeneca (AZN)](https://longbridge.com/en/news/293338532.md)
- [AstraZeneca asthma inhaler Trixeo wins positive EU CHMP opinion for approval](https://longbridge.com/en/news/293742333.md)
- [AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law Firm](https://longbridge.com/en/news/293539668.md)
- [Astrazeneca Plc $AZN Shares Sold by Compound Planning Inc.](https://longbridge.com/en/news/293816614.md)